Skip to main content
Varietly

Legal

Medical Disclaimer

Varietly tells you what treatment costs. It cannot tell you whether it is right for you.

This is pricing data, not medical advice

Varietly compares what GLP-1 telehealth providers charge. It does not assess whether a medication, a dose, or a provider is appropriate for you. Nothing here establishes a doctor-patient relationship, and no part of the site should be used to diagnose or treat a condition.

Talk to a clinician before you change anything

Starting, stopping, switching, or adjusting the dose of a GLP-1 medication is a clinical decision. Price should never be the reason you make one without a prescriber involved. If you are considering a switch, take the comparison to your clinician rather than acting on it directly.

Compounded medication carries different risks

Compounded semaglutide and tirzepatide are not FDA-approved products and are not evaluated for safety, effectiveness, or quality the way brand medications are. Varietly lists compounded options because they are what providers sell, not as an endorsement that they are equivalent to the brand product.

Availability and eligibility are decided by the provider

Whether you can get a given medication depends on clinical eligibility, state law, insurance, and supply — all determined by the provider, not by Varietly. A plan appearing on this site does not mean you will be approved for it.

In an emergency

Do not use this site for urgent medical concerns. If you think you are having a medical emergency, call 911 or go to the nearest emergency department immediately. If you are in the United States and need immediate mental-health or suicide-crisis support, call or text 988.

Reporting a side effect

Report suspected side effects to your prescriber. In the United States you can also report to the FDA's MedWatch programme. Varietly cannot receive, assess, or forward adverse event reports.

Last updated September 23, 2026.